Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Evaluation of pneumonia virus of mice as a possible human pathogen.

Brock LG, Karron RA, Krempl CD, Collins PL, Buchholz UJ.

J Virol. 2012 May;86(10):5829-43. doi: 10.1128/JVI.00163-12. Epub 2012 Mar 21.

2.

Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.

Buchholz UJ, Ward JM, Lamirande EW, Heinze B, Krempl CD, Collins PL.

J Virol. 2009 Feb;83(4):1969-80. doi: 10.1128/JVI.02041-08. Epub 2008 Dec 3.

3.

The response of aged mice to primary infection and re-infection with pneumonia virus of mice depends on their genetic background.

Shrivastava P, Watkiss E, van Drunen Littel-van den Hurk S.

Immunobiology. 2016 Mar;221(3):494-502. doi: 10.1016/j.imbio.2015.10.008. Epub 2015 Nov 18.

PMID:
26621546
4.

Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.

Cortjens B, Lutter R, Boon L, Bem RA, van Woensel JB.

PLoS One. 2016 Dec 22;11(12):e0168779. doi: 10.1371/journal.pone.0168779. eCollection 2016.

5.

Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

van Helden MJ, van Kooten PJ, Bekker CP, Gröne A, Topham DJ, Easton AJ, Boog CJ, Busch DH, Zaiss DM, Sijts AJ.

Vaccine. 2012 Oct 5;30(45):6382-8. doi: 10.1016/j.vaccine.2012.08.027. Epub 2012 Aug 29.

6.

The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.

Dyer KD, Garcia-Crespo KE, Glineur S, Domachowske JB, Rosenberg HF.

Viruses. 2012 Dec;4(12):3494-510. Review.

7.

Innate and adaptive immune response to pneumonia virus of mice in a resistant and a susceptible mouse strain.

Watkiss ER, Shrivastava P, Arsic N, Gomis S, van Drunen Littel-van den Hurk S.

Viruses. 2013 Jan 21;5(1):295-320. doi: 10.3390/v5010295.

9.

Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Walsh KB, Teijaro JR, Brock LG, Fremgen DM, Collins PL, Rosen H, Oldstone MB.

J Virol. 2014 Jun;88(11):6281-93. doi: 10.1128/JVI.00464-14. Epub 2014 Mar 26.

10.

Blunted inflammatory and mucosal IgA responses to pneumonia virus of mice in C57BL/6 neonates are correlated to reduced protective immunity upon re-infection as elderly mice.

Shrivastava P, Atanley E, Sarkar I, Watkiss E, Gomis S, van Drunen Littel-van den Hurk S.

Virology. 2015 Nov;485:233-43. doi: 10.1016/j.virol.2015.07.019. Epub 2015 Aug 25.

11.

Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.

Claassen EA, van Bleek GM, Rychnavska ZS, de Groot RJ, Hensen EJ, Tijhaar EJ, van Eden W, van der Most RG.

Virology. 2007 Nov 10;368(1):17-25. Epub 2007 Jul 16.

12.

Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.

Garcia-Crespo KE, Chan CC, Gabryszewski SJ, Percopo CM, Rigaux P, Dyer KD, Domachowske JB, Rosenberg HF.

Antiviral Res. 2013 Mar;97(3):270-9. doi: 10.1016/j.antiviral.2012.12.022. Epub 2012 Dec 26.

13.

Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo.

Heinze B, Frey S, Mordstein M, Schmitt-Gräff A, Ehl S, Buchholz UJ, Collins PL, Staeheli P, Krempl CD.

J Virol. 2011 May;85(9):4071-84. doi: 10.1128/JVI.01365-10. Epub 2011 Feb 9.

14.

Roles of the PVM M2-1, M2-2 and P gene ORF 2 (P-2) proteins in viral replication.

Dibben O, Thorpe LC, Easton AJ.

Virus Res. 2008 Jan;131(1):47-53. Epub 2007 Sep 18.

PMID:
17881076
15.

Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice.

Percopo CM, Qiu Z, Phipps S, Foster PS, Domachowske JB, Rosenberg HF.

J Immunol. 2009 Jul 1;183(1):604-12. doi: 10.4049/jimmunol.0802270.

16.

Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.

Claassen EA, van der Kant PA, Rychnavska ZS, van Bleek GM, Easton AJ, van der Most RG.

J Immunol. 2005 Nov 15;175(10):6597-604.

17.

Eosinophils and their interactions with respiratory virus pathogens.

Rosenberg HF, Dyer KD, Domachowske JB.

Immunol Res. 2009;43(1-3):128-37. doi: 10.1007/s12026-008-8058-5.

18.

Glucocorticoid administration accelerates mortality of pneumovirus-infected mice.

Domachowske JB, Bonville CA, Ali-Ahmad D, Dyer KD, Easton AJ, Rosenberg HF.

J Infect Dis. 2001 Dec 15;184(12):1518-23. Epub 2001 Dec 3.

PMID:
11740726
19.

Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice.

Barends M, de Rond LG, Dormans J, van Oosten M, Boelen A, Neijens HJ, Osterhaus AD, Kimman TG.

Clin Exp Allergy. 2004 Mar;34(3):488-96.

PMID:
15005745
20.

Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.

Maunder HE, Taylor G, Leppard KN, Easton AJ.

Vaccine. 2015 Nov 27;33(48):6641-9. doi: 10.1016/j.vaccine.2015.10.105. Epub 2015 Nov 1.

PMID:
26529077

Supplemental Content

Support Center